150 related articles for article (PubMed ID: 34087869)
61. Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
Kennedy GA; Marlton P; Cobcroft R; Gill D
Br J Haematol; 2000 Dec; 111(4):1103-5. PubMed ID: 11167746
[TBL] [Abstract][Full Text] [Related]
62. [Induction and maintenance therapy in all-trans retinoic acid with relapsed acute promyelocytic leukemia].
Takitani K; Kawamura N; Yamaguchi H; Morinobu W; Yoshida N; Watanabe K; Miyake M; Tatsumi K; Mino M
Rinsho Ketsueki; 1995 Feb; 36(2):147-52. PubMed ID: 7715086
[TBL] [Abstract][Full Text] [Related]
63. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
[TBL] [Abstract][Full Text] [Related]
64. [Oral All-transretinoic acid administration in intubated patients with acute promyelocytic leukemia].
Bargetzi MJ; Tichelli A; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1996 Nov; 126(45):1944-5. PubMed ID: 8946598
[TBL] [Abstract][Full Text] [Related]
65. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Sakamaki H; Tsubaki K; Saito K; Ohno R
Cancer Chemother Pharmacol; 1997; 40 Suppl():S30-5. PubMed ID: 9272131
[TBL] [Abstract][Full Text] [Related]
66. Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis.
Elliott S; Taylor K; White S; Rodwell R; Marlton P; Meagher D; Wiley J; Taylor D; Wright S; Timms P
Blood; 1992 Apr; 79(8):1916-9. PubMed ID: 1562718
[TBL] [Abstract][Full Text] [Related]
67. Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report.
Li Y; Yu J; Xu Q; Zhang K
Medicine (Baltimore); 2021 Dec; 100(48):e28076. PubMed ID: 35049232
[TBL] [Abstract][Full Text] [Related]
68. Successful treatment of acute promyelocytic leukemia in a patient with prosthetic heart valves: a case report and review of the literature.
Haghighat S; Rezvani A; Mokhtari M
J Med Case Rep; 2021 May; 15(1):260. PubMed ID: 33941263
[TBL] [Abstract][Full Text] [Related]
69. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
70. Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.
Jeddi R; Kacem K; Ben Neji H; Mnif S; Gouider E; Aissaoui L; Ben Amor R; Ben Lakhal R; Ben Abid H; Belhadjali Z; Meddeb B
Hematology; 2008 Jun; 13(3):142-6. PubMed ID: 18702871
[TBL] [Abstract][Full Text] [Related]
71. Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia.
Wu X; Wang X; Qien X; Liu H; Ying J; Yang Z; Yao H
Am J Hematol; 1993 Jul; 43(3):183-9. PubMed ID: 8352233
[TBL] [Abstract][Full Text] [Related]
72. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
[TBL] [Abstract][Full Text] [Related]
73. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
74. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
[TBL] [Abstract][Full Text] [Related]
75. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
76. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
Hisatake J; Shimozuma J
Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
[TBL] [Abstract][Full Text] [Related]
77. Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.
Advani SH; Nair R; Bapna A; Gladstone B; Kadam P; Saikia TK; Parekh PM; Gopal R; Nair CN
Am J Hematol; 1999 Feb; 60(2):87-93. PubMed ID: 9929098
[TBL] [Abstract][Full Text] [Related]
78. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
[TBL] [Abstract][Full Text] [Related]
79. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
[TBL] [Abstract][Full Text] [Related]
80. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
